Antibodies
Showing 9976 - 10000 of >10,000
Hepatocellular Carcinoma Trial in Guangzhou, Kaiping, Hengyang (Lenvatinib, PD-1 antibody, Placebo)
Withdrawn
- Hepatocellular Carcinoma
- Lenvatinib
- +2 more
-
Guangzhou, Guangdong, China
- +4 more
Apr 30, 2019
Viral Hepatitis in Uremic Patients in Taiwan
Unknown status
- Uremia
- Viral Hepatitis
- blood sampling
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Mar 2, 2019
End Stage Renal Disease, Antibody Mediated Rejection Trial in Madison (Belatacept, Tacrolimus withdrawal,
Withdrawn
- End Stage Renal Disease
- Antibody Mediated Rejection
- Belatacept
- +5 more
-
Madison, WisconsinUniversity of Wiscsonsin Hospital and Clinics
Dec 13, 2018
Depressive Disorder, Major, Depression Trial in Lublin (Probiotic supplementation + gluten-free diet, Placebo supplementation +
Unknown status
- Depressive Disorder, Major
- Depression
- Probiotic supplementation + gluten-free diet
- +3 more
-
Lublin, Poland1st Department of Psychiatry, Psychotherapy and Early Interventi
Mar 14, 2019
Glioblastoma Multiforme Trial in United States (biological, drug, other)
Completed
- Glioblastoma Multiforme
- bevacizumab
- +2 more
-
Scottsdale, Arizona
- +304 more
Oct 4, 2019
Melanoma Trial in Tampa (MAGE-A3 ASCI injections without Poly IC:LC, MAGE-A3 ASCI injections with Poly IC:LC)
Terminated
- Melanoma
- MAGE-A3 ASCI injections without Poly IC:LC
- MAGE-A3 ASCI injections with Poly IC:LC
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Dec 18, 2019
Allergic Rhinitis Trial in Canada, United States (Dupilumab, Timothy Grass SCIT, Placebo matching dupilumab)
MDS Trial in Saint-Petersburg (Nivolumab, Azacitidine, Fludarabine)
Terminated
- Myelodysplastic Syndromes
- Nivolumab
- +7 more
-
Saint-Petersburg, Russian FederationFirst Pavlov State Medical University of St. Petersburg
Apr 3, 2019
Malignant Glioma Trial in Durham (Sym004 - 18 mg/kg, Sym004 - 24 mg/kg)
Completed
- Malignant Glioma
- Sym004 - 18 mg/kg
- Sym004 - 24 mg/kg
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center
Jul 23, 2020
Lymphoproliferative Disorder Trial in Worldwide (rituximab, cyclophosphamide, methylprednisolone)
Completed
- Lymphoproliferative Disorder
- rituximab
- +3 more
-
Birmingham, Alabama
- +77 more
Jul 25, 2019
Inhalational Anthrax Trial in Dallas (ETI-204, Placebo)
Completed
- Inhalational Anthrax
- ETI-204
- Placebo
-
Dallas, TexasCovance Clinical Research Inc.
Jan 9, 2019
Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis
Terminated
- Hepatomegaly
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 23, 2019
NSCLC Trial in Guangzhou (anti-PD1 antibody-activated TILs)
Unknown status
- Non-small Cell Lung Cancer
- anti-PD1 antibody-activated TILs
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University, Cancer Center
Apr 3, 2019
Advanced or Metastatic Melanoma, Advanced or Metastatic NSCLC Trial in France (immune-checkpoint inhibitors therapies)
Unknown status
- Advanced or Metastatic Melanoma
- Advanced or Metastatic NSCLC
- immune-checkpoint inhibitors therapies
-
Marseille, Bouches Du Rhône, France
- +8 more
Sep 25, 2019
Respiratory Syncytial Virus (RSV) Hospitalizations in Infants
Unknown status
- Syncytial Virus Respiratory Infection
- +3 more
- Not applicable (no intervention)
- (no location specified)
Oct 29, 2019
Corona Virus Disease Trial in Copenhagen, Hillerød (RoActemra iv, RoActemra sc, Kevzara sc)
Terminated
- Corona Virus Disease
- RoActemra iv
- +3 more
-
Copenhagen, Denmark
- +1 more
Oct 8, 2020
Sickle Cell Disease Trial in Chicago (procedure, drug, radiation)
Terminated
- Sickle Cell Disease
- Haploidentical Transplant
- +4 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Aug 22, 2019
Vaccination, Immunization Trial in Hertfordshire, London (Synflorix, Prevenar13)
Withdrawn
- Vaccination
- Immunization
- Synflorix
- Prevenar13
-
Hertfordshire, United Kingdom
- +1 more
Aug 27, 2019
Pertussis, Pertussis Vaccines Trial in Hungary (Blood sampling, Data collection)
Completed
- Pertussis
- Pertussis Vaccines
- Blood sampling
- Data collection
-
Budapest, Hungary
- +4 more
Nov 15, 2019
Early Breast Cancer Trial in Worldwide (PF-05280014, Taxotere®, Paraplatin®)
Completed
- Early Breast Cancer
- PF-05280014
- +3 more
-
Fountain Valley, California
- +51 more
Dec 19, 2018